Skip to product information
1 of 7

Aestura

Atobarrier 365 Cream face Moisturizer for Dry Sensitive Skin - 10ml

Atobarrier 365 Cream face Moisturizer for Dry Sensitive Skin - 10ml

SKU:8809643078931

Regular price EGP 394.00
Regular price EGP 500.00 Sale price EGP 394.00
Sale Sold out

Out of stock

Quantity
Free shipping for orders over 1,200.00 EGP

AESTURA Atobarrier 365 Cream 10 ml is a high-density ceramide capsule moisturizer designed for dry and sensitive skin. This travel-size cream helps moisturize and strengthen the skin barrier using patented Capsule Technology and DermaON® complex.

How to use: Apply evenly to clean skin morning and evening after toner and serum. Gently press to aid absorption. Visible capsules melt smoothly into the skin.

Clinical insights (brand-reported):

  • 100% of participants showed improvement in barrier and hydration after one application (instrumental, 32 women).
  • Skin sensitivity reduced by 51% after 4 weeks of daily use (self-scoring, 22 women).

Ideal for dryness, skin sensitivity, and skin barrier support. Mini 10 ml / 0.33 fl.oz size perfect for travel or trial. Made for daily use on dry and sensitive skin.

Note: Results may vary. This is a cosmetic moisturizer, not a medicine. Patch test recommended. For external use only.

Key Features:

  • Contains approximately 1 million high-density ceramide capsules (in larger sizes; proportional in this mini) that help replenish moisture gaps in the skin barrier.
  • Capsule Technology helps ceramides remain within the skin barrier for up to 18 hours (ex vivo test on human skin).
  • Provides long-lasting hydration up to 120 hours after one application (instrumental result).
  • Helps strengthen the compromised skin barrier and supports moisture retention.
  • Dermatologist tested.
  • Accepted by the National Eczema Association.
  • Fragrance-free, alcohol-free, non-comedogenic formula suitable for dry, sensitive, and eczema-prone skin.
  • Also suitable for post-microneedling care and eczema-prone baby skin (as per brand guidance).
View full details